These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7481790)

  • 1. New clues found to how some people live with HIV.
    Cohen J
    Science; 1995 Nov; 270(5238):917-8. PubMed ID: 7481790
    [No Abstract]   [Full Text] [Related]  

  • 2. SIV vaccine for AIDS.
    Farthing CF; Sullivan JL
    Science; 1998 Jan; 279(5347):14-5. PubMed ID: 9441400
    [No Abstract]   [Full Text] [Related]  

  • 3. Why do we not have an HIV vaccine and how can we make one?
    Burton DR; Moore JP
    Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
    [No Abstract]   [Full Text] [Related]  

  • 4. Attenuated HIV vaccine: caveats.
    Ruprecht RM; Baba TW; Liska V
    Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
    [No Abstract]   [Full Text] [Related]  

  • 5. Defective HIV may hold clue to effective vaccine.
    Baker R
    BETA; 1995 Dec; ():9. PubMed ID: 11363018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live HIV vaccines--how safe?
    Dittmer U; Stahl-Hennig C; Hunsmann G
    Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC
    Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
    Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
    [No Abstract]   [Full Text] [Related]  

  • 11. An attenuated vaccine for AIDS?
    Beale J
    Lancet; 1995 May; 345(8961):1318-9. PubMed ID: 7752750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1999: a time to re-evaluate AIDS vaccine strategies.
    Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
    J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsidering an attenuated vaccine for AIDS.
    Beale J
    Lancet; 1996 Feb; 347(8998):344-5. PubMed ID: 8598696
    [No Abstract]   [Full Text] [Related]  

  • 14. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine.
    Hayami M; Igarashi T
    Leukemia; 1997 Apr; 11 Suppl 3():95-7. PubMed ID: 9209310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A candidate live inactivatable attenuated vaccine for AIDS.
    Chakrabarti BK; Maitra RK; Ma XZ; Kestler HW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9810-5. PubMed ID: 8790413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
    Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
    Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian/human immunodeficiency virus(89.6) expressing the chemokine genes MIP-1alpha, RANTES, or lymphotactin.
    Waterman PM; Kitabwalla M; Tikhonov I; Pauza CD
    Viral Immunol; 2003; 16(1):35-44. PubMed ID: 12725687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.